Company: TVRD
Filing Date: 2025-02-14
Form Type: 424B3
Source: 0001104659-25-014310
Chunk: 930

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: 424B3
Chunk 930
---
 | ​ | ​                                      | ​ |      2,258 | ​ | ​ | ​ | ​    | ​ |      2,117 | ​ | ​ |
| Total operating expenses                                                  | ​ | ​ | ​                                      | ​ |     17,305 | ​ | ​ | ​ | ​    | ​ |     14,001 | ​ | ​ |
| Loss from operations                                                      | ​ | ​ | ​                                      | ​ |    -17,305 | ​ | ​ | ​ | ​    | ​ |    -14,001 | ​ | ​ |
| Interest income                                                           | ​ | ​ | ​                                      | ​ |        615 | ​ | ​ | ​ | ​    | ​ |      1,005 | ​ | ​ |
| Net loss                                                                  | ​ | ​ | ​                                      | $ |    -16,690 | ​ | ​ | ​ | ​    | $ |    -12,996 | ​ | ​ |
| Net loss per share attributable to common stockholders, basic and diluted | ​ | ​ | ​                                      | $ |      -0.87 | ​ | ​ | ​ | ​    | $ |      -0.68 | ​ | ​ |
| Weighted-average common shares outstanding, basic and diluted             | ​ | ​ | ​                                      | ​ | 19,192,595 | ​ | ​ | ​ | ​    | ​ | 19,134,072 | ​ | ​ |

The accompanying notes are an integral part of these unaudited condensed financial statements. F-116

TABLE OF CONTENTS Tvardi Therapeutics, Inc. CONDENSED Statements of Redeemable Convertible Preferred Stock
and Stockholders’ Deficit
(Amounts in thousands, except share amounts)
(Unaudited)

| ​                                 
 ​                                 | ​ 
 ​ | ​ 
 ​ | Redeemable ConvertiblePreferred Stock 
 Shares                                |   |            |   | ​ | ​ | Amount |   |        |   | ​ 
 ​ | ​ 
 ​ | ​ 
 ​ | Common Stock 
 Shares       |   |            |   | ​ | ​ | Amount |   |    |   | ​ 
 ​ | ​ | AdditionalPaid-InCapital |   |       |   | ​ | ​ | AccumulatedDeficit |   |         |   | ​ | ​ | AccumulatedOtherComprehensiveLoss |   |   |   | ​ | ​ | TotalStockholders’Deficit |   |         |